Breaking News

WuXi launches parenteral formulation manufacturing line

This expansion demonstrates the company’s continuous commitment to enhance its injectable drug product platform

Quotient Sciences announces manufacturing and clinical testing partnership

Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain

Andelyn to manufacture gene therapy for infantile neuroaxonal dystrophy

The disease leads to neurodegeneration in the nervous system of patients accompanied by an inflammatory response and causes progressive loss of men...

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, t...

Aptamer opens state-of-the-art laboratories in York, England

The new facilities will support the increased demand for Optimer technology

C4XD signs $402 million licence with AstraZeneca

C4XD is eligible to receive upfront and pre-clinical payments of $16 million, plus development and commercial milestones, and tiered mid-single dig...

Increasing patient compliance with ion exchange excipient taste masking

With a significant number of individuals reporting that they find it difficult to swallow tablets or capsules, and more people admitting to not tak...

Inspiration from unexpected places

How pharmaceutical companies can learn from advances in nicotine delivery

Want print copies of Manufacturing Chemist delivered to your door?

Catch up with Manufacturing Chemist in print, at your leisure

Merck invests €290m in biosafety testing capacity

The company aims to increase its Group sales to approximately €25 billion by 2025

Enabling oligonucleotide therapeutics with precision targeting methods

Oligonucleotides are a rapidly growing class of therapeutics. This modality appears to offer highly favourable therapeutic characteristics such as...

Manufacturing Chemist LIVE 2022 in review (part I)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

ABPI: “New antibiotics key against resistance infections”

In 2019, it was estimated that 1.2 million deaths globally, were due to antibiotic-resistant infections

Orodispersibles and minitablets: optimising patient compliance by improving the sensory properties with isomalt

Orally dispersible minitablets are a drug dosage form that can help to improve patient compliance among children and others who have difficulty swa...

Malvern Panalytical and Applied Photophysics announce distribution agreement

Partnership targets high-throughput protein stability screening to accelerate drug development

Formulation considerations for paediatric populations: finding the right dosage form for better adherence

To address the challenges of paediatric formulations, specialised technology platforms are often needed to provide ease of application and improve...